This study analyzed data from 196 NIA-funded Alzheimer’s disease and related dementia (AD/ADRD) clinical trials to identify common eligibility criteria and their potential to disproportionately exclude participants by race/ethnicity. Analyses revealed that most trials had criteria that may be a barrier to achieving diverse and equitable recruitment into AD/ADRD clinical trials.
Mitchell AK, et al. Analysis of eligibility criteria in Alzheimer’s and related dementias clinical trials . Scientific Reports. 2024. Epub July 1. doi: 10.1038/s41598-024-65767-x.
Recruit & Retain Participants 2024-09-03T00:00:00Z Barriers & Facilitators Trial Design Underrepresented Research Articles